AAAAAA

   
Results: 1-10 |
Results: 10
Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: Potential physiological and clinical relevance
Authors: Ruscetti, FW Bartelmez, SH
Citation: Fw. Ruscetti et Sh. Bartelmez, Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: Potential physiological and clinical relevance, INT J HEMAT, 74(1), 2001, pp. 18-25
Prevalence of HTLV-I-associated T-cell lymphoma
Authors: Poiesz, BJ Papsidero, LD Ehrlich, G Sherman, M Dube, S Poiesz, M Dillon, K Ruscetti, FW Slamon, D Fang, C Williams, A Duggan, D Glaser, J Gottlieb, A Goldberg, J Ratner, L Phillips, P Han, T Friedman-Kien, A Siegal, F Rai, K Sawitsky, A Sheremata, LWA Dosik, H Cunningham, C Montagna, R
Citation: Bj. Poiesz et al., Prevalence of HTLV-I-associated T-cell lymphoma, AM J HEMAT, 66(1), 2001, pp. 32-38
Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation
Authors: Fang, JY Mikovits, JA Bagni, R Petrow-Sadowski, CL Ruscetti, FW
Citation: Jy. Fang et al., Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation, J VIROLOGY, 75(20), 2001, pp. 9753-9761
The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1
Authors: Li, BQ Wetzel, MA Mikovits, JA Henderson, EE Rogers, TJ Gong, WH Li, YY Ruscetti, FW Wang, JM
Citation: Bq. Li et al., The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1, BLOOD, 97(10), 2001, pp. 2941-2947
Effects of growth hormone and prolactin on hematopoiesis
Authors: Welniak, LA Tian, ZG Sun, R Keller, JR Richards, S Ruscetti, FW Murphy, WJ
Citation: La. Welniak et al., Effects of growth hormone and prolactin on hematopoiesis, LEUK LYMPH, 38(5-6), 2000, pp. 435-445
Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines
Authors: Akiyama, Y Watanabe, M Maruyama, K Ruscetti, FW Wiltrout, RH Yamaguchi, K
Citation: Y. Akiyama et al., Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines, GENE THER, 7(24), 2000, pp. 2113-2121
BP1, a new homeobox gene, is frequently expressed in acute leukemias
Authors: Haga, SB Fu, S Karp, JE Ross, DD Williams, DM Hankins, WD Behm, F Ruscetti, FW Chang, M Smith, BD Becton, D Raimondi, SC Berg, PE
Citation: Sb. Haga et al., BP1, a new homeobox gene, is frequently expressed in acute leukemias, LEUKEMIA, 14(11), 2000, pp. 1867-1875
Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry
Authors: Li, BQ Fu, T Yao, DY Mikovits, JA Ruscetti, FW Wang, JM
Citation: Bq. Li et al., Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry, BIOC BIOP R, 276(2), 2000, pp. 534-538
Functional characterization of a novel hematopoietic stem cell and its place in the c-kit maturation pathway in bone marrow cell development
Authors: Ortiz, M Wine, JW Lohrey, N Ruscetti, FW Spence, SE Keller, JR
Citation: M. Ortiz et al., Functional characterization of a novel hematopoietic stem cell and its place in the c-kit maturation pathway in bone marrow cell development, IMMUNITY, 10(2), 1999, pp. 173-182
Induction of CD4(+) T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta(1)
Authors: Zeller, JC Panoskaltsis-Mortari, A Murphy, WJ Ruscetti, FW Narula, S Roncarolo, MG Blazar, BR
Citation: Jc. Zeller et al., Induction of CD4(+) T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta(1), J IMMUNOL, 163(7), 1999, pp. 3684-3691
Risultati: 1-10 |